Remove Article Remove Computational Chemistry Remove Research
article thumbnail

Patent Highlights: Allosteric AR Modulators, Glycogen Synthase Inhibitors, and More

Drug Hunter

This article highlights million-dollar molecules that were recently in the news with related patent applications that give clues to their structures and properties. Oral Allosteric AR Modulator s request a trial You don’t have time to read everything, but you can’t afford to fall behind.

article thumbnail

How the AI revolution can accelerate early drug discovery

Drug Target Review

From 2005 to 2008 he carried out a DPhil (PhD) at Oxford on nanomaterials for quantum computation, followed by postdoctoral work on the prediction of crystal structures at University College London. Matthew subsequently put his computational chemistry skills to use in the defence sector. Matthew is a chartered chemist.

Drugs 105
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Accelerated Computing Holds the Key to Democratized Drug Discovery

Nvidia Developer: Drug Discovery

A recent article examining the transformational role of GPU computing and deep learning in drug discovery is showing hope that this trend may soon reverse. There are 10 60 drug-like molecules to consider, so researchers need a representation of the chemical space that is organized and searchable.

Drugs 52
article thumbnail

Reaching cruising altitude: New discovery tools to target RNA

Dark Matter Blog

However, since most small molecule drugs target proteins in the cell, the vast majority of target identification methods available to research scientists are aimed at identifying interactions between small molecules and proteins. Our expedition gains altitude After that initial result, it was all hands on deck.

RNA 52